189 Épisodes

  1. Targeting FGFR in Urothelial Cancer and Beyond

    Publié: 23/03/2021
  2. Expert Answers to HCP Questions on Pancreatic Cancer Treatment

    Publié: 22/03/2021
  3. Expert Answers to HCP Questions on CAR T-Cell Therapies in Lymphoma

    Publié: 18/03/2021
  4. Frequently Asked Questions on Emerging Antibody–Drug Conjugates in the Treatment of Advanced Non-Small-Cell Lung Cancer

    Publié: 17/03/2021
  5. Expert Answers to HCP Questions on CAR T-Cell Therapies in Myeloma and Management of Key Toxicities

    Publié: 12/03/2021
  6. Expert Insights on Highlights From ASH 2020 on Multiple Myeloma

    Publié: 12/03/2021
  7. Expert Insights on Key Data From ASH 2020 on Acute and Chronic Leukemias

    Publié: 26/02/2021
  8. Expert Insight on Key Data From WCLC 2020 in Early-Stage Lung Cancer

    Publié: 24/02/2021
  9. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Argentina

    Publié: 22/02/2021
  10. Expert Insights on Key Data From ASH 2020 on Nonmalignant Hematologic Disorders

    Publié: 10/02/2021
  11. Expert Insights on Key Data From ASH 2020 on Myelodysplastic Syndromes and Myeloproliferative Neoplasms

    Publié: 05/02/2021
  12. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Italy

    Publié: 04/02/2021
  13. Expert Answers to Questions on Contemporary Management of Hemophilia A

    Publié: 04/02/2021
  14. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From the United States

    Publié: 01/02/2021
  15. An Expert Overview of Immunotherapy for Advanced HCC

    Publié: 19/01/2021
  16. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Spain

    Publié: 08/01/2021
  17. Expert Answers to Pathologist Questions on New Biomarkers for Precision Therapy in Lung Cance

    Publié: 28/12/2020
  18. Application of Individualized Treatment for CLL/SLL: Novel Agents, Combinations, and Sequencing Therapy: FAQ

    Publié: 24/12/2020
  19. Practical Insights on Key Data From ESMO 2020 Informing Precision Medicine in NSCLC

    Publié: 21/12/2020
  20. Immunotherapy for Advanced HCC: Experts Answer Clinician Questions

    Publié: 17/12/2020

8 / 10

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.

Visit the podcast's native language site